中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共2条，第1-2条 帮助

已选(0)清除 条数/页：   排序方式：
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文
BLOOD ADVANCES, 2023, 卷号: 7
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe;  Zhang, Qingyuan;  Liberati, Anna Marina;  Cao, Junning;  Yang, Haiyan;  Hao, Siguo;  Hu, Jianda;  Zhou, Keshu;  Petrini, Mario;  Russo, Filomena;  Zhang, Huilai;  Sang, Wei;  Ji, Jie;  Ferreri, Andres Jose Maria;  Damaj, Gandhi Laurent;  Liu, Hui;  Zhang, Wei;  Ke, Xiaoyan;  Ghiggi, Chiara;  Huang, Sha;  Li, Xiaotong;  Yao, Hui;  Paik, Jason;  Noveotny, William;  Zhou, Wenxiao;  Zhu, Hongji;  Zinzani, Pier Luigi
收藏  |  浏览/下载：26/0  |  提交时间：2023/11/10
Tislelizumab, a PD-1 inhibitor for relapsed/refractory mature T/NK-cell neoplasms: Results from a phase 2 study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe;  Zhang, Qingyuan;  Liberati, Anna Marina;  Cao, Junning;  Yang, Haiyan;  Hao, Siguo;  Hu, Jianda;  Zhou, Keshu;  Russo, Filomena;  Zhang, Huilai;  Sang, Wei;  Ji, Jie;  Liu, Hui;  Huang, Sha;  Zinzani, Pier Luigi
收藏  |  浏览/下载：33/0  |  提交时间：2022/12/23